Is 1.25 mg tirzepatide actually doing anything for weight loss?

What is the 1.25 mg dose actually for, if not weight loss?

When tirzepatide was studied, the trials built in a starting dose to reduce the nausea, vomiting and digestive discomfort that can come with GLP-1-based medicines. The 1.25 mg pen is that starter: its role is system adjustment, not weight reduction. The NHS tirzepatide medicines page describes the escalation schedule clearly, treatment typically begins at 2.5 mg, moving upward in roughly four-week steps toward doses where the real clinical effect sits.

So if you are at 1.25 mg and wondering whether anything is happening, the honest answer is: the medicine is working, just not in the way you might expect. Your gut is slowing down. Appetite signals are starting to shift. Most people find nausea is at its most noticeable here, which is precisely why this phase exists, pressing straight to a higher dose would make the side-effect burden worse for many people, not better.

If you are reading this before starting treatment, our detailed 1.25 mg guide covers what to expect during the first pen in plain terms, and our 1.25 mg Mounjaro page has further information specific to this starting dose.

Does the evidence show any weight loss at this dose?

The SURMOUNT-1 trial (2,539 adults, 72 weeks, published in the New England Journal of Medicine) tested tirzepatide at 5 mg, 10 mg and 15 mg against placebo. The trial was not designed to measure 1.25 mg as a sustained dose; participants moved through it on their way to higher doses. So there is no standalone published trial figure for 1.25 mg as a maintenance dose, because that was never the intention.

What the data does show is a clear dose-response relationship: more of the medicine, more weight lost, up to around 20–21% average body-weight reduction at 15 mg. That gradient matters. It tells us the effective range is further up the schedule, not at the bottom. Early changes some patients notice at 1.25 mg (eating a bit less, feeling full sooner) are real biological effects, but modest compared with what the same medicine does at 10 or 15 mg.

For context on how results build as the dose increases, the 5 mg effectiveness page picks up where this one leaves off.

How long should someone stay on 1.25 mg before expecting results?

The licensed dose schedule, as described in the medicine's Summary of Product Characteristics on the Electronic Medicines Compendium (eMC), sets 1.25 mg as a four-week starting period before moving to 2.5 mg. Expecting meaningful weight loss within those four weeks is setting the wrong benchmark, this is the adjustment window, not the treatment phase.

Practically speaking, most people start tirzepatide when a clear stretch of routine life is ahead. If your first pen lands just before a long holiday or over a period of significant stress, your prescriber is worth a conversation. That is the kind of timing question our FAQs touch on, and the kind our prescribers answer through aftercare.

Once on 2.5 mg and above, most people begin to see measurable weight changes. The 2.5 mg effectiveness page looks at what shifts at that next step.

What if you feel like nothing is happening on 1.25 mg?

That feeling is common and almost always accurate, in the sense that significant weight reduction at this dose is not the expected outcome. The instinct to question whether the medicine is working, to wonder whether you are one of the people it will not work for, is understandable. Most people who stay with the schedule find that changes become noticeable by the 5 mg phase.

What matters more at 1.25 mg is tolerability. Are GI side effects manageable? Is there anything unexpected? Those questions belong with a prescriber. Jumping to a higher dose early, or stopping entirely because this phase feels flat, both carry risks, one of side-effect overload, the other of abandoning a medicine that had not yet been properly tested at an appropriate dose.

If you are thinking about which dose is likely to produce the best results for you personally, the guide to effective Mounjaro doses pulls together the evidence across the full schedule. And if you are considering starting treatment through a regulated UK pharmacy, our free consultation is reviewed the same day by a real prescriber on our clinical team.